14.09.2018 • NewsDede WillamsInvista

Invista to add 40,000 t of PA 6.6 in China

Invista to add 40,000 t of PA 6.6 in China (c) Invista
Invista to add 40,000 t of PA 6.6 in China (c) Invista

Invista has announced plans to add 40,000 t/y of PA 6.6 polymerization capacity at its plant in Shanghai Chemical Industry Park (SCIP). The Chinese investment will lift output at the site to 190,000 t/y by 2020.

The US polyamide giant headquartered at Wichita, Kansas, already operates a plant for hexamethylenediamine (HMD) at the Shanghai site, producing 215,000 t/y of the feedstock. It is also expected to locate its recently announced adiponitrile (ADN) production facility with capacity of at least 300,000 t/y in the vast chemical park.

Elsewhere, Invista is retrofitting ADN technology at Butachimie, its joint venture with Solvay in France, up to 2019 and is also investing in the nylon feedstock at Victoria, Texas in the US.

Construction is on the PA 6.6 upgrade is due to begin in mid-2019. Invista calculates that it has invested more than $1 billion in its polyamide chain over the past five years. It plans to invest a similar sum going forward, while continuing to evaluate the market for future opportunities, said Pat Brown, vice president of nylon polymer.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.